In response to the opioid epidemic that began in the late 1990s, drug distributors are facing significant legal consequences. The crisis, fueled by the aggressive marketing of highly addictive painkillers, has resulted in nearly 645,000 overdose deaths from opioids between the start of the epidemic and 2021, according to the CDC. To date, litigation has led to approximately $50 billion in settlements. Recently, six health benefit plans from Ohio, Oklahoma, Michigan, and New York have filed lawsuits arguing that they were forced to cover the costs associated with opioid overuse, including emergency room visits and treatments for opioid use disorder.
The legal battles, centralized in the Ohio Northern District Court, have been ongoing since late 2017. Settlement negotiations have been in progress since 2022. The anticipated settlement funds are expected to be distributed among more than 40,000 health plans, excluding certain government entities and major national insurers such as UnitedHealth, Aetna, and Cigna. Additionally, McKesson, Cardinal, and Cencora (formerly AmerisourceBergen) have already agreed to a $21 billion settlement with state and local governments, which includes creating a clearinghouse for opioid distribution data to support anti-diversion efforts.
